Phibro Animal Health Corporation
NASDAQ:PAHC
23.5 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,017.679 | 977.889 | 942.3 | 833.4 | 800.4 | 828 | 820 | 764.3 | 751.5 | 748.591 | 691.9 | 653.151 | 654.101 | 618.333 | 594.2 | 537.1 | 511.4 | 453 | 398.4 | 364.4 | 354.4 | 337.8 | 328.7 | 319.7 | 323 |
| Cost of Revenue
| 705.192 | 679.652 | 656.9 | 562 | 543.5 | 563.4 | 553.1 | 516 | 512.5 | 512.219 | 484.1 | 474.187 | 489.962 | 471.668 | 439.5 | 407.5 | 389.7 | 341.8 | 307.3 | 293.1 | 265.2 | 248.6 | 247.4 | 250.3 | 249.6 |
| Gross Profit
| 312.487 | 298.237 | 285.4 | 271.4 | 256.9 | 264.6 | 266.9 | 248.3 | 239 | 236.372 | 207.8 | 178.964 | 164.139 | 146.665 | 154.7 | 129.6 | 121.7 | 111.2 | 91.1 | 71.3 | 89.2 | 89.2 | 81.3 | 69.4 | 73.4 |
| Gross Profit Ratio
| 0.307 | 0.305 | 0.303 | 0.326 | 0.321 | 0.32 | 0.325 | 0.325 | 0.318 | 0.316 | 0.3 | 0.274 | 0.251 | 0.237 | 0.26 | 0.241 | 0.238 | 0.245 | 0.229 | 0.196 | 0.252 | 0.264 | 0.247 | 0.217 | 0.227 |
| Reseach & Development Expenses
| 29.194 | 24.395 | 20.832 | 17.759 | 13.738 | 12.083 | 9.998 | 9.442 | 11.029 | 9.511 | 8.212 | 6.638 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 101.9 | 84.6 | 81.3 | 76.2 | 68.1 | 66.9 | 63.4 | 63.3 | 70.6 | 63.9 | 59.3 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 220.875 | 226.39 | 206.4 | 196.5 | 187.7 | 181.4 | 168 | 150.3 | 153.3 | 148.704 | 144 | 122.233 | 114.814 | 105.429 | 101.9 | 84.6 | 81.3 | 76.2 | 68.1 | 66.9 | 63.4 | 63.3 | 70.6 | 63.9 | 59.3 |
| Other Expenses
| 13.215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.151 | 0.4 | -0.593 | -0 | 3.6 | 11.1 | 14 | -0 | -0 | -17.9 | -0 | 0 | -0 | -1.5 |
| Operating Expenses
| 250.069 | 226.39 | 206.4 | 196.5 | 187.7 | 181.4 | 168 | 150.3 | 153.3 | 148.704 | 144 | 122.233 | 114.814 | 105.429 | 101.9 | 88.2 | 92.4 | 90.2 | 68.1 | 66.9 | 45.5 | 63.3 | 70.6 | 63.9 | 57.8 |
| Operating Income
| 62.418 | 71.847 | 46.295 | 43.015 | 36.859 | 73.301 | 98.9 | 97.9 | 85.7 | 87.668 | 63.8 | 56.731 | 49.325 | 41.236 | 52.8 | 41.4 | 29.3 | 21.1 | 23 | 4.4 | 43.7 | 25.9 | 10.6 | 5.4 | 15.7 |
| Operating Income Ratio
| 0.061 | 0.073 | 0.049 | 0.052 | 0.046 | 0.089 | 0.121 | 0.128 | 0.114 | 0.117 | 0.092 | 0.087 | 0.075 | 0.067 | 0.089 | 0.077 | 0.057 | 0.047 | 0.058 | 0.012 | 0.123 | 0.077 | 0.032 | 0.017 | 0.049 |
| Total Other Income Expenses Net
| -51.502 | -2.455 | 26.005 | 23.485 | 18.641 | 15.664 | 1.1 | -2.5 | 7.6 | 5.4 | -24.6 | -3.254 | -0.792 | -14.837 | -33.2 | -43.5 | -27.4 | -27.4 | -30.9 | -25.8 | -19.8 | -18.9 | -21 | -17.1 | -1.7 |
| Income Before Tax
| 10.916 | 54.071 | 72.3 | 66.5 | 55.5 | 71.5 | 88.1 | 80.5 | 76.8 | 78.763 | 6.3 | 17.848 | 13.114 | -7.889 | 19.6 | -2.1 | 1.9 | -6.3 | -7.9 | -21.4 | 23.9 | 7 | -10.4 | -11.7 | 14 |
| Income Before Tax Ratio
| 0.011 | 0.055 | 0.077 | 0.08 | 0.069 | 0.086 | 0.107 | 0.105 | 0.102 | 0.105 | 0.009 | 0.027 | 0.02 | -0.013 | 0.033 | -0.004 | 0.004 | -0.014 | -0.02 | -0.059 | 0.067 | 0.021 | -0.032 | -0.037 | 0.043 |
| Income Tax Expense
| 8.5 | 21.465 | 23.2 | 12.1 | 22 | 16.8 | 23.2 | 15.9 | -6 | 18.483 | 9.4 | -7.043 | 6.138 | 5.033 | 3.8 | 3.4 | 2.6 | 0.4 | 5.2 | 2.1 | 7.8 | 9.8 | 14.8 | -0.4 | 3.9 |
| Net Income
| 2.416 | 32.606 | 49.175 | 54.385 | 33.552 | 54.7 | 64.9 | 64.6 | 82.7 | 60.28 | -3.1 | 24.891 | 6.976 | -12.922 | 42.1 | -8.3 | 2.2 | -6.7 | -13.1 | -22.1 | 12.9 | -17.6 | -51.8 | -14.9 | 10.1 |
| Net Income Ratio
| 0.002 | 0.033 | 0.052 | 0.065 | 0.042 | 0.066 | 0.079 | 0.085 | 0.11 | 0.081 | -0.004 | 0.038 | 0.011 | -0.021 | 0.071 | -0.015 | 0.004 | -0.015 | -0.033 | -0.061 | 0.036 | -0.052 | -0.158 | -0.047 | 0.031 |
| EPS
| 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | 1.35 | 1.61 | 1.63 | 2.11 | 1.55 | -0.099 | 0.82 | 0.23 | -0.42 | 1.09 | -0.21 | 0.057 | -0.17 | -0.22 | -0.37 | 0.22 | -0.29 | -0.86 | -0.25 | 0.17 |
| EPS Diluted
| 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | 1.35 | 1.61 | 1.61 | 2.07 | 1.51 | -0.096 | 0.82 | 0.23 | -0.42 | 1.09 | -0.21 | 0.057 | -0.17 | -0.22 | -0.37 | 0.22 | -0.29 | -0.86 | -0.25 | 0.17 |
| EBITDA
| 98.596 | 108.487 | 79 | 74.9 | 69.2 | 83.4 | 98.9 | 97.9 | 85.8 | 109.521 | 63.9 | 75.745 | 67.533 | 57.646 | 12.8 | -48.3 | -22.1 | -22.88 | -26.51 | -28.79 | 10.76 | -14.21 | -42.34 | -22.59 | 11.67 |
| EBITDA Ratio
| 0.097 | 0.111 | 0.084 | 0.09 | 0.086 | 0.101 | 0.121 | 0.128 | 0.114 | 0.146 | 0.092 | 0.116 | 0.103 | 0.093 | 0.022 | -0.09 | -0.043 | -0.051 | -0.067 | -0.079 | 0.03 | -0.042 | -0.129 | -0.071 | 0.036 |